Approval · Notice of Compliance 24646 · 2020
MELPHALAN FOR INJECTION: Notice of Compliance 24646
Issued November 19, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24646
- Date
- November 19, 2020
- Company
- Auro Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ALKERAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MELPHALAN FOR INJECTION | 02508214 | Approved |
Medicinal ingredients
- MELPHALAN HCL 50 MG per VIAL